Skip to content

Conventional Collagen Crosslinking in Young Keratoconus

Evaluation of Conventional Collagen Crosslinking in Young Keratoconus.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008175
Acronym
PED-CXL
Enrollment
21
Registered
2013-12-11
Start date
2012-01-31
Completion date
2013-11-30
Last updated
2013-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Keywords

paediatric, keratoconus, collagen cross linking

Brief summary

Keratoconus is a chronic progressive non - inflammatory disorder characterised by progressive steepening and thinning of cornea and high myopic astigmatism, accounting for poor visual acuity in such individuals. Keratoconus seems to be more advanced on presentation, in young patients. The investigators intend to evaluate the effectiveness of conventional collagen cross linking in young patients diagnosed with keratoconus.

Detailed description

Keratoconus is progressive ectatic corneal disorder characterised by progressive corneal thinning, steep corneal curvatures and usually associated with high irregular myopic astigmatism. The major problems concerning keratoconus in young patients are; 1. Rapid rates of progression in young keratoconic corneas as compared to adults. 2. Poor biomechanical properties of young corneas. 3. Poor quality of vision, which predisposes to a very poor quality of life. 4. High rates of complications and failure post keratoplasty in young patients. The investigators intend to evaluate the effectiveness of conventional collagen crosslinking in young patients with keratoconus with regards to keratometric indices and visual acuity.

Interventions

RADIATIONConventional CXL

Crosslinking was done according to the standard protocol using hypo-osmolar riboflavin (\<0.1%) to saturate the cornea following epithelial debridement and ultra - violet light of 370nm with energy density of 3 milliwatts/cm2 with riboflavin and distilled water alternated every 2 minutes was used for the procedure..

Sponsors

Vasan Eye Care Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and below. * Patients diagnosed to have keratoconus at presentation and willing for follow - up at regular intervals post treatment.

Exclusion criteria

* Any disease causing abnormal topography other than keratoconus. * Any ocular condition predisposing towards poor vision (retinal , lens problems)

Design outcomes

Primary

MeasureTime frameDescription
Change in Keratometric indices1 monthsThe keratometric readings in the steepest and flattest meridians, along with the average K readings were compared pre and post treatment using conventional collagen cross linking technique at 1 month post cross linking.

Secondary

MeasureTime frameDescription
Improvement in vision12 monthsComparison of visual rehabilitation was done as improvements noted in Snellen line numbers and best corrected visual acuity (B.C.V.A) converted to decimals, pre and post treatment at 1,3,6,12 months post treatment.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026